• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Viant Acquires Meraqi Medical

Share:

September 16, 2019

Viant Acquires Meraqi Medical

Viant, a leading global services provider to the medical device industry, announced today that it has acquired Meraqi Medical. It is the fourth acquisition that Viant has completed in two years to expand its clinical market expertise, global footprint, and portfolio of solutions.

Headquartered in Silicon Valley, Meraqi extends Viant’s expertise in front-end design and development for interventional technologies and bioelectronics, and expands Viant’s platform within minimally invasive surgical devices. Meraqi also adds a West Coast design and development (D&D) hub to Viant’s East Coast D&D Center and global network of manufacturing sites. Viant will incorporate Meraqi’s engineering expertise and design capabilities into its suite of solutions that support customers with expanding their product offerings, optimizing their supply chains, and improving quality while managing costs.

“Meraqi stands out for its deep technical knowledge, passion for innovation and agility to help customers advance their technologies,” said Declan Smyth, president of Franchise, Viant. “Adding Meraqi’s expertise to Viant’s breadth of capabilities and global scale provides our customers with expanded access to end-to-end solutions for all their medtech needs.”

“Joining Viant will give our customers access to a world class, quality focused organization with global manufacturing facilities and scale,” said founder Al Hershey. “Additionally, this will enable Meraqi to accelerate the expansion of our capabilities and better serve our customers. Our shared passion for supporting innovative devices to address unmet patient needs and loving what we do makes this a very exciting time for our two companies and for our customers.”

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Since partnering with Water Street Healthcare Partners and JLL Partners in 2016, Viant has grown to become one of the world’s premier outsourced manufacturers of medical devices. The company has expanded its portfolio of design, development, and manufacturing capabilities to offer end-to-end solutions to medical device organizations. Most recently, Viant announced the appointment of Alton E. Shader, a veteran medical device leader, to chief executive officer to accelerate the company’s strategic expansion.

Date: September 16, 2019

Source: PR Newswire

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • What hospitals need for successful AI: a digital baseWhat hospitals need for successful AI: a digital base
  • AI in healthcare – not so fast? Study outlines challenges, dangers for machine learningAI in healthcare – not so fast? Study outlines challenges, dangers for machine learning
  • Validic Announces High-Frequency Data Support, Delivering Minute-to-Minute Readings From Wearables, Home Health DevicesValidic Announces High-Frequency Data Support, Delivering Minute-to-Minute Readings From Wearables, Home Health Devices
  • Centinel Spine Announces Continued Partnership with Performance Tech MotorsportsCentinel Spine Announces Continued Partnership with Performance Tech Motorsports
  • Lodo Therapeutics Acquires Hibiskus BioPharma And Licenses Rights To Novel Proteasome InhibitorsLodo Therapeutics Acquires Hibiskus BioPharma And Licenses Rights To Novel Proteasome Inhibitors
  • Former Apple CEO on The Biggest Trendlines in Health TechnologyFormer Apple CEO on The Biggest Trendlines in Health Technology
  • FDA Grants Priority Review to Takeda’s Dengue VaccineFDA Grants Priority Review to Takeda’s Dengue Vaccine
  • Somatus Scoops Up $64M Series C FundingSomatus Scoops Up $64M Series C Funding

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications